EUVIMEDEUVIMED entdecken
Open Access

[Expression of Concern] ISL1 promotes cancer progression and inhibits cisplatin sensitivity in triple‑negative breast cancer cells

Yang Zhang, Lu Wang, Peng Gao, Zhiguo Sun, Ning Li, Yanqin Lu, Jianglun Shen, Jian Sun, Yiming Yang, Hao Dai, Haifeng Cai

International Journal of Molecular Medicine · 06.05.2026 · 58 (1) · 1-1

DOI: 10.3892/ijmm.2026.5846 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Medicine, online erschienen am 06.05.2026. Verfasst von Yang Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: The Second Department of Breast Surgery, Tangshan People's Hospital, Tangshan, Hebei 063000, P.R. China. Hauptthemen laut MEDLINE: Cisplatin, Triple Negative Breast Neoplasms, LIM-Homeodomain Proteins, Transcription Factors. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinTriple Negative Breast NeoplasmsLIM-Homeodomain ProteinsTranscription FactorsDrug Resistance, NeoplasmHumansCell Line, TumorFemaleDisease ProgressionGene Expression Regulation, NeoplasticAntineoplastic AgentsCell MovementCell Proliferation

Stichwörter der Autor:innen

cancer progressioncisplatin sensitivityislet 1triple-negative breast cancer

Substanzen

CisplatinLIM-Homeodomain ProteinsTranscription FactorsAntineoplastic Agents

Autor:innen und Institutionen

  • The Second Department of Breast Surgery, Tangshan People's Hospital, Tangshan, Hebei 063000, P.R. China.
  • The Second Department of Chemoradiotherapy, Tangshan People's Hospital, Tangshan, Hebei 063000, P.R. China.

Zitieren

APA

Zhang, Y., Wang, L., Gao, P., Sun, Z., Li, N., Lu, Y., Shen, J., Sun, J., Yang, Y., Dai, H., & Cai, H. (2026). [Expression of Concern] ISL1 promotes cancer progression and inhibits cisplatin sensitivity in triple‑negative breast cancer cells. International Journal of Molecular Medicine, 58(1), 1-1. https://doi.org/10.3892/ijmm.2026.5846

Vancouver

Zhang Y, Wang L, Gao P, Sun Z, Li N, Lu Y, et al. [Expression of Concern] ISL1 promotes cancer progression and inhibits cisplatin sensitivity in triple‑negative breast cancer cells. International Journal of Molecular Medicine. 2026;58(1):1-1. doi:10.3892/ijmm.2026.5846

BibTeX
@article{Zhang2026,
  author = {Zhang, Yang and Wang, Lu and Gao, Peng and Sun, Zhiguo and Li, Ning and Lu, Yanqin and Shen, Jianglun and Sun, Jian and Yang, Yiming and Dai, Hao and Cai, Haifeng},
  title = {[Expression of Concern] ISL1 promotes cancer progression and inhibits cisplatin sensitivity in triple‑negative breast cancer cells},
  journal = {International Journal of Molecular Medicine},
  year = {2026},
  volume = {58},
  number = {1},
  pages = {1--1},
  doi = {10.3892/ijmm.2026.5846}
}
Kostenlos starten →